BioNTech (BNTX) News Today $102.34 +5.82 (+6.03%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period BioNTech (NasdaqGS:BNTX) Sees 11% Stock Increase Over Last WeekApril 14 at 3:42 PM | uk.finance.yahoo.comSummit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing CompetitionApril 14 at 10:42 AM | seekingalpha.comAPG Asset Management N.V. Invests $5.16 Million in BioNTech SE (NASDAQ:BNTX)APG Asset Management N.V. acquired a new position in BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 46,900 shares of the company's stock, valued at approximately $5,161,000. Other large iApril 14 at 5:22 AM | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Sold by Quinn Opportunity Partners LLCQuinn Opportunity Partners LLC decreased its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 11.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 356,194 shares of the company's stock after sellingApril 13 at 7:52 AM | marketbeat.comScotia Capital Inc. Acquires 30,143 Shares of BioNTech SE (NASDAQ:BNTX)Scotia Capital Inc. increased its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 20.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 175,224 shares of the company's stock after buying an additioApril 13 at 6:27 AM | marketbeat.comCenterBook Partners LP Has $22.12 Million Stock Holdings in BioNTech SE (NASDAQ:BNTX)CenterBook Partners LP grew its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 62.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 194,118 shares of the company's stock after purchasing an additional 74,65April 11, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Buys New Position in BioNTech SE (NASDAQ:BNTX)Arrowstreet Capital Limited Partnership bought a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 30,827 shares of the company's stock, valued at apApril 11, 2025 | marketbeat.comFmr LLC Boosts Stock Holdings in BioNTech SE (NASDAQ:BNTX)Fmr LLC increased its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 22.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,701,476 shares of the company's stock after buying an additional 1,401,547 shares duApril 10, 2025 | marketbeat.comBioNTech price target raised to $140 from $139 at Morgan StanleyApril 9, 2025 | markets.businessinsider.comFranklin Resources Inc. Buys 133,402 Shares of BioNTech SE (NASDAQ:BNTX)Franklin Resources Inc. raised its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 3,942.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 136,786 shares of the company's stock after buying an additional 133,402 sApril 9, 2025 | marketbeat.comAristides Capital LLC Has $2.05 Million Holdings in BioNTech SE (NASDAQ:BNTX)Aristides Capital LLC lifted its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 51.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,010 shares of the company's stock after purchasinApril 8, 2025 | marketbeat.comRaymond James Financial Inc. Purchases Shares of 5,122 BioNTech SE (NASDAQ:BNTX)Raymond James Financial Inc. acquired a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 5,122 shares of the company's stock, valued at approximately $584,000. SApril 8, 2025 | marketbeat.comBNTX Quantitative Stock Analysis - Benjamin GrahamApril 7, 2025 | nasdaq.comHC Wainwright Brokers Boost Earnings Estimates for BioNTechBioNTech SE (NASDAQ:BNTX - Free Report) - Equities research analysts at HC Wainwright increased their Q1 2025 earnings per share (EPS) estimates for BioNTech in a research report issued to clients and investors on Tuesday, April 1st. HC Wainwright analyst R. Burns now forecasts that the company wApril 6, 2025 | marketbeat.comCinctive Capital Management LP Buys Shares of 14,760 BioNTech SE (NASDAQ:BNTX)Cinctive Capital Management LP purchased a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 14,760 shares of the company's stock, valuedApril 6, 2025 | marketbeat.comSei Investments Co. Sells 33,727 Shares of BioNTech SE (NASDAQ:BNTX)Sei Investments Co. lessened its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 59.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,221 shares of the company's stock after sellinApril 6, 2025 | marketbeat.comPictet Asset Management Holding SA Decreases Holdings in BioNTech SE (NASDAQ:BNTX)Pictet Asset Management Holding SA lowered its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 8.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,956 shares of the company's stockApril 5, 2025 | marketbeat.comHead to Head Contrast: BioNTech (NASDAQ:BNTX) versus Cyclo Therapeutics (NASDAQ:CYTH)April 5, 2025 | americanbankingnews.comHC Wainwright Has Positive Outlook for BioNTech Q1 EarningsApril 5, 2025 | americanbankingnews.comBioNTech SE Announces Virtual Annual General Meeting for 2025April 4, 2025 | tipranks.comBioNTech Enters Oversold Territory (BNTX)April 3, 2025 | nasdaq.comBioNTech Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)April 3, 2025 | nasdaq.comSA Asks: How will changes at FDA impact vaccine makers?April 2, 2025 | msn.comBioNTech SE and University of Pennsylvania Finalize Agreements Amidst SettlementApril 2, 2025 | tipranks.comIs BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?April 2, 2025 | insidermonkey.comBioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC WainwrightHC Wainwright cut their target price on BioNTech from $150.00 to $145.00 and set a "buy" rating on the stock in a report on Tuesday.April 2, 2025 | marketbeat.comGroupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)Groupama Asset Managment increased its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 30.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 86,725 shares of the company's stock after buying an addiApril 2, 2025 | marketbeat.comEdmond DE Rothschild Holding S.A. Grows Stock Position in BioNTech SE (NASDAQ:BNTX)Edmond DE Rothschild Holding S.A. raised its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 31.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 97,310 shares of the company's stock after aApril 2, 2025 | marketbeat.comPromising Potential of BioNTech’s BNT327 in ES-SCLC Treatment: Analyst’s InsightApril 2, 2025 | tipranks.comBioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from BrokeragesBioNTech SE (NASDAQ:BNTX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eighteen brokerages that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has giApril 2, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?BioNTech (NASDAQ:BNTX) Shares Gap Down - Here's What HappenedApril 1, 2025 | marketbeat.comTruist Financial Remains a Buy on BioNTech SE (BNTX)April 1, 2025 | markets.businessinsider.comModerna stock tumbles after FDA shakeupMarch 31, 2025 | za.investing.comVaccine, gene therapy makers fall after Peter Marks resignationMarch 31, 2025 | markets.businessinsider.comVaccine stocks fall after key FDA official resigns in protest of RFK Jr.March 31, 2025 | cnbc.comBiotech stocks tumble on reports FDA's top vaccine regulator to leaveMarch 31, 2025 | reuters.comAnalysts’ Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX)March 29, 2025 | markets.businessinsider.comPromising Phase 2 Results and Revenue Potential Drive Buy Rating for BioNTech’s BNT327 in SCLCMarch 29, 2025 | tipranks.comMitsubishi UFJ Trust & Banking Corp Has $21.37 Million Holdings in BioNTech SE (NASDAQ:BNTX)Mitsubishi UFJ Trust & Banking Corp trimmed its holdings in BioNTech SE (NASDAQ:BNTX - Free Report) by 1.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 187,516 shares of the companyMarch 29, 2025 | marketbeat.comCureVac Shares Rise on Patent Confirmation Amid BioNTech LawsuitMarch 28, 2025 | marketwatch.comCureVac: Patent Win Notable, But Won't Answer More Fundamental QuestionsMarch 28, 2025 | seekingalpha.comLooking At BioNTech's Recent Unusual Options ActivityMarch 28, 2025 | benzinga.com12 Most Promising Biotech Stocks According to Wall Street AnalystsMarch 26, 2025 | insidermonkey.comBioNTech SE’s BNT327 Shows Promising Results in SCLC, Earning a Buy Rating from AnalystMarch 24, 2025 | tipranks.comAnalysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP), BioNTech SE (BNTX) and Alnylam Pharma (ALNY)March 21, 2025 | markets.businessinsider.comBioNTech SE (BNTX) Gets a Buy from Goldman SachsMarch 21, 2025 | markets.businessinsider.comLingohr Asset Management GmbH Acquires New Shares in BioNTech SE (NASDAQ:BNTX)Lingohr Asset Management GmbH bought a new position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 3,170 shares of the company's stock, valued at approximately $357,000.March 21, 2025 | marketbeat.comRefractory Metastatic Melanoma Pipeline Report 2025, with Focus on BioNTech SE, Y-mAbs and Therapeutics SeagenMarch 20, 2025 | globenewswire.comCharles Schwab Investment Management Inc. Purchases 53,319 Shares of BioNTech SE (NASDAQ:BNTX)Charles Schwab Investment Management Inc. increased its position in BioNTech SE (NASDAQ:BNTX - Free Report) by 39.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 187,355 shares of theMarch 20, 2025 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA lowered its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 4.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,295,817 shares of the company'March 18, 2025 | marketbeat.com Remove Ads Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼1.370.83▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼1311▲BNTX Articles Average Week Remove Ads Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today argenx News Today Beigene News Today Summit Therapeutics News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Moderna News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
